A detailed history of North Star Investment Management Corp. transactions in Eli Lilly & CO stock. As of the latest transaction made, North Star Investment Management Corp. holds 8,857 shares of LLY stock, worth $6.8 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
8,857
Previous 8,839 0.2%
Holding current value
$6.8 Million
Previous $8 Million 1.95%
% of portfolio
0.55%
Previous 0.59%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$772.14 - $960.02 $13,898 - $17,280
18 Added 0.2%
8,857 $7.85 Million
Q2 2024

Aug 05, 2024

SELL
$724.87 - $909.04 $484,938 - $608,147
-669 Reduced 7.04%
8,839 $8 Million
Q1 2024

Apr 30, 2024

BUY
$592.2 - $792.28 $296,100 - $396,140
500 Added 5.55%
9,508 $7.4 Million
Q4 2023

Jan 10, 2024

SELL
$525.19 - $619.13 $57,770 - $68,104
-110 Reduced 1.21%
9,008 $5.25 Million
Q3 2023

Nov 06, 2023

SELL
$434.7 - $599.3 $89,113 - $122,856
-205 Reduced 2.2%
9,118 $4.9 Million
Q2 2023

Aug 02, 2023

BUY
$350.74 - $468.98 $19,290 - $25,793
55 Added 0.59%
9,323 $4.37 Million
Q1 2023

Apr 27, 2023

BUY
$310.63 - $364.82 $259,376 - $304,624
835 Added 9.9%
9,268 $3.18 Million
Q4 2022

Jan 11, 2023

BUY
$321.55 - $374.67 $41,158 - $47,957
128 Added 1.54%
8,433 $0
Q3 2022

Nov 02, 2022

BUY
$296.48 - $337.87 $296 - $337
1 Added 0.01%
8,305 $2.69 Million
Q2 2022

Jul 19, 2022

BUY
$278.73 - $327.27 $28,987 - $34,036
104 Added 1.27%
8,304 $2.69 Million
Q1 2022

May 03, 2022

BUY
$234.69 - $291.66 $47,172 - $58,623
201 Added 2.51%
8,200 $2.35 Million
Q4 2021

Feb 07, 2022

SELL
$224.85 - $279.04 $29,680 - $36,833
-132 Reduced 1.62%
7,999 $2.21 Million
Q2 2021

Jul 13, 2021

SELL
$180.55 - $233.54 $7,041 - $9,108
-39 Reduced 0.48%
8,131 $1.87 Million
Q1 2021

Apr 19, 2021

SELL
$164.32 - $212.72 $9,037 - $11,699
-55 Reduced 0.67%
8,170 $1.53 Million
Q4 2020

Jan 12, 2021

SELL
$130.46 - $172.63 $3,261 - $4,315
-25 Reduced 0.3%
8,225 $1.39 Million
Q2 2020

Jul 16, 2020

SELL
$136.42 - $164.18 $189,623 - $228,210
-1,390 Reduced 14.42%
8,250 $1.35 Million
Q1 2020

Apr 23, 2020

SELL
$119.05 - $147.35 $627,155 - $776,239
-5,268 Reduced 35.34%
9,640 $1.34 Million
Q4 2019

Jan 29, 2020

SELL
$106.92 - $132.43 $6,629 - $8,210
-62 Reduced 0.41%
14,908 $1.96 Million
Q1 2019

Apr 10, 2019

BUY
$111.31 - $131.02 $6,678 - $7,861
60 Added 0.4%
14,970 $1.94 Million
Q1 2018

Apr 13, 2018

BUY
$74.21 - $87.6 $28,941 - $34,164
390 Added 2.69%
14,910 $1.15 Million
Q4 2017

Jan 11, 2018

BUY
$81.94 - $87.89 $38,511 - $41,308
470 Added 3.35%
14,520 $1.23 Million
Q3 2017

Oct 06, 2017

BUY
$77.07 - $85.54 $1.08 Million - $1.2 Million
14,050
14,050 $1.2 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track North Star Investment Management Corp. Portfolio

Follow North Star Investment Management Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of North Star Investment Management Corp., based on Form 13F filings with the SEC.

News

Stay updated on North Star Investment Management Corp. with notifications on news.